Crash Course in Cures: Treatment Options in AML

Eliza joined HealthTree in March 2026 as the Leukemia Patient Health Education Manager. Prior to joining HealthTree, she completed a Master’s Degree in Public Health from Brigham Young University and worked with a variety of underserved populations in government and healthcare settings, including Americorps and Utah Health Department. When not in office, Eliza enjoys reading, writing and learning new things about the world.

Dr. Dugan is a hematology/oncology specialist and the physician lead for the transplant and cellular therapy department for Novant Health Cancer Institute. He is a member of the American Society of Hematology, as well as the American Society for Transplant and Cellular therapy. His membership in these organizations keep him up to date on the latest research and treatment options in the field. He is also actively engaged in clinical research focused on acute leukemia, with the goal of finding new, targeted therapies that improve disease control and survival while limiting side effects and maintaining a good quality of life through treatment.